The purpose of this study is to examine weather treatment with anthocyanins will affect lipid profile, markers of inflammation and oxidative stress in addition to antioxidative level in serum to the better in persons with increased risk of dementia. The purpose of this study is to examine weather treatment with anthocyanins will increase the score of relevant tests of cognitive function. The investigators will do an open pilot study where patients receive anthocyanin for 16 weeks. 34 patients are expected to be included. In addition we will include 20 healthy Controls.
Design, method and material: The investigators will first do an open pilot study where 30 people will receive anthocyanins for 16 weeks. The investigators aim to recruit persons with increased risk of cognitive reduction: persons over 50 years with stable coronary heart disease (CAD) from the cardiology department Stavanger University Hospital. In addition will persons with mild cognitive impairment or mild dementia be included from the memory outpatient clinic, Stavanger University Hospital. Blood will be taken by venepuncture by an experienced nurse, centrifuged and handled in according to standardized procedures. The patients will be tested in relevant tests of cognitive function at inclusion and after 16 weeks. At inclusion the patients will be tested in Mini Mental State Examination (MMSE) and Geriatric depression scale (GDS) to make sure that the patients meet the inclusion criteria. At inclusion and after 16 weeks the patients will be tested in Word List Memory Word List Recall Word List Recognition, Trail Making Test A + B and Stroop Word and Colour test. From the healthy controls blood will be taken at inclusion and study end.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
54
Open pilot study. 35 patients will receive anthocyanin 160 mg x 2 p.o for 16 weeks
Stavanger University Hospital
Stavanger, Norway
Inflammation as measured by cytokines in blood
IL1, IL6, IL10, TNFa
Time frame: 16 weeks
Effect on blood lipids as measured by serum Levels of Cholesterol, triglycerides, cholesterol metabolites
Serum Level measurement of Cholesterol, triglycerides, cholesterol metabolites
Time frame: 16 weeks
Effects on oxidative stress as measured by Blood Levels of lipid peroxidation markers, 4-hydroxymenal protein oxydation marker, total protein carbonyl
Blood Levels of lipid peroxidation markers, 4-hydroxymenal protein oxydation marker, total protein carbonyl
Time frame: 16 weeks
Effects on antioxidants as measured by Blood levels of vitamin E, vitamin C, vitamin A, total plasma antioxidant capacity, glutathion
Blood levels of vitamin E, vitamin C, vitamin A, total plasma antioxidant capacity, glutathion
Time frame: 16 weeks
Number of participants With adverse events
Active questioning for adverse events
Time frame: 16 weeks
Effects on memory (CERAD memory test)
CERAD memory test, immediate and delayed score
Time frame: 16 weeks
Effects on attention (Trail making A and B)
Trail making A and B
Time frame: 16 weeks
Effects on executive functioning (Stroop test)
Stroop test
Time frame: 16 weeks
Effects on blood pressure
Blood pressure (mm/Hg) in sitting position
Time frame: 16 weeks
Effects on heart rate (ECG)
ECG
Time frame: 16 weeks
Effect on Cardiac output (Blood Levels of natriuretic peptides)
Blood Levels of natriuretic peptides
Time frame: 16 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.